| scholarly article | Q13442814 |
| P2093 | author name string | Shou-Chuan Shih | |
| Hung-I Yeh | |||
| Charles Jia-Yin Hou | |||
| Chung-Lieh Hung | |||
| Chuan-Chuan Liu | |||
| Cheng-Ho Tsai | |||
| Yih-Jer Wu | |||
| Ying-Hsiang Lee | |||
| P2860 | cites work | Quantification of coronary artery calcium using ultrafast computed tomography. | Q52867038 |
| Liver and pancreatic fat content and metabolism in healthy monozygotic twins with discordant physical activity | Q57256272 | ||
| Arterial Calcification and Not Lumen Stenosis Is Highly Correlated With Atherosclerotic Plaque Burden in Humans: A Histologic Study of 723 Coronary Artery Segments Using Nondecalcifying Methodology | Q58492269 | ||
| Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes | Q71131546 | ||
| Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia | Q73382038 | ||
| Metabolic syndrome, its preeminent clusters, incident coronary heart disease and all-cause mortality--results of prospective analysis for the Atherosclerosis Risk in Communities study | Q80542965 | ||
| Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA) | Q81526909 | ||
| Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease | Q81691178 | ||
| Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 | Q83161496 | ||
| Coronary Artery Calcium Score Combined With Framingham Score for Risk Prediction in Asymptomatic Individuals | Q22252997 | ||
| Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
| Metabolic syndrome: a multiplex cardiovascular risk factor | Q28218776 | ||
| Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | Q29619465 | ||
| Adverse prognosis associated with the metabolic syndrome in established coronary artery disease: data from the EUROPA trial | Q31114345 | ||
| Metabolic syndrome in a Taiwanese metropolitan adult population | Q33298695 | ||
| Hepatic steatosis and subclinical cardiovascular disease in a cohort enriched for type 2 diabetes: the Diabetes Heart Study | Q33375822 | ||
| Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. | Q35011142 | ||
| Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference | Q35115696 | ||
| Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis | Q35822510 | ||
| Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. | Q36160498 | ||
| Non-alcoholic fatty liver disease and increased risk of cardiovascular disease | Q36592831 | ||
| Imaging of hepatic steatosis and fatty sparing | Q36659719 | ||
| Fatty liver: a novel component of the metabolic syndrome | Q36906553 | ||
| Cardiovascular morbidity and mortality associated with the metabolic syndrome | Q39513407 | ||
| Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome | Q44385945 | ||
| Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus | Q44853673 | ||
| Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis | Q45016055 | ||
| Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults | Q45027927 | ||
| Effect of weight loss on liver free fatty acid uptake and hepatic insulin resistance | Q46289032 | ||
| Calcification of the coronary arteries. | Q46294410 | ||
| Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity | Q46410788 | ||
| Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT). | Q46685858 | ||
| Overproduction of large VLDL particles is driven by increased liver fat content in man. | Q46931621 | ||
| Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes | Q46944958 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | fatty liver disease | Q6058862 |
| P304 | page(s) | 586785 | |
| P577 | publication date | 2011-12-27 | |
| P1433 | published in | Radiology Research and Practice | Q26853951 |
| P1476 | title | The severity of Fatty liver disease relating to metabolic abnormalities independently predicts coronary calcification | |
| P478 | volume | 2011 |
| Q36336631 | Association between nonalcoholic fatty liver disease and coronary artery calcification in postmenopausal women |
| Q27010592 | Cardiovascular dysfunction in patients with liver cirrhosis |
| Q54760091 | Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance? |
| Q36968917 | Impact of fitness versus obesity on routinely measured cardiometabolic risk in young, healthy adults |
| Q46220517 | Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study. |
| Q40064196 | Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification in a Northern Chinese Population: a Cross Sectional Study |
| Q30435948 | Nonalcoholic fatty liver disease: updates in noninvasive diagnosis and correlation with cardiovascular disease |
Search more.